Fascin+ cells within CD138+ cell-infiltrated and noninfiltrated areas
Patient no. . | Fascin+ cells, mean ± SD . | |
---|---|---|
CD138+-infiltrated . | Noninfiltrated . | |
87 | 14.6 ± 1.9 | 0.8 ± 0.8 |
88 | 19.4 ± 2.1 | 0.4 ± 0.8 |
89 | 15.4 ± 1.9 | 0.2 ± 0.4 |
90 | 2.2 ± 1.2 | 1.4 ± 0.8 |
91 | 15.8 ± 1.7 | 0.2 ± 0.4 |
Patient no. . | Fascin+ cells, mean ± SD . | |
---|---|---|
CD138+-infiltrated . | Noninfiltrated . | |
87 | 14.6 ± 1.9 | 0.8 ± 0.8 |
88 | 19.4 ± 2.1 | 0.4 ± 0.8 |
89 | 15.4 ± 1.9 | 0.2 ± 0.4 |
90 | 2.2 ± 1.2 | 1.4 ± 0.8 |
91 | 15.8 ± 1.7 | 0.2 ± 0.4 |
Consecutive sections from bone marrow biopsies from 5 patients with recurring MM were stained with CD138 or fascin. Areas with CD138+ cell infiltrates were first identified, and infiltrated (myeloma) and noninfiltrated areas (normal) were then re-examined for fascin staining on serial sections. The number of fascin+ cell bodies with dendritic projections (excluding capillary endothelial cells) were counted per high-powered field (×1000), and averaged for 5 fields. For all 5 patients combined, P < .001 comparing the number of DCs in the CD138+ versus CD138− areas.